Breakthrough Pain Assessment Tool

2014 ◽  
Author(s):  
Katherine Webber ◽  
Andrew N. Davies ◽  
Giovambattista Zeppetella ◽  
Martin R. Cowie
Keyword(s):  
Pain Assessment ◽  
Assessment Tool ◽  
Breakthrough Pain

scholarly journals The Alberta Breakthrough Pain Assessment Tool for Cancer Patients: A Validation Study Using a Delphi Process and Patient Think-Aloud Interviews

2008 ◽  
Vol 35 (2) ◽  
pp. 136-152 ◽  
Author(s):  
Neil A. Hagen ◽  
Carla Stiles ◽  
Cheryl Nekolaichuk ◽  
Patricia Biondo ◽  
Linda E. Carlson ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Validation Study ◽  
Pain Assessment ◽  
Assessment Tool ◽  
Breakthrough Pain ◽  
Delphi Process ◽  
Think Aloud

scholarly journals Validation of the Dutch Version of the Breakthrough Pain Assessment Tool in Patients With Cancer

2020 ◽  
Vol 59 (3) ◽  
pp. 709-716.e2
Author(s):  
Wendy H. Oldenmenger ◽  
Anne Lucas ◽  
Gertruud F.H. van der Werff ◽  
Katherine Webber ◽  
Dick Visser ◽  
...  
Keyword(s):  
Pain Assessment ◽  
Assessment Tool ◽  
Breakthrough Pain ◽  
Dutch Version ◽  
Patients With Cancer

Assessment

2019 ◽  
pp. 17-24
Author(s):  
Andrew Davies
Keyword(s):  
Pain Assessment ◽  
Assessment Tool ◽  
Clinical Skills ◽  
Breakthrough Pain ◽  
Successful Management ◽  
Detailed History ◽  
Pain Questionnaire ◽  
Inappropriate Treatment ◽  
Background Pain

Successful management of breakthrough pain depends on adequate assessment and adequate re-assessment. The assessment of pain primarily depends on basic clinical skills, that is, taking a detailed history and performing a thorough examination. Inadequate assessment may lead to ineffective or even inappropriate treatment. The objectives of assessment are to determine the aetiology and pathophysiology of the pain, and factors that indicate or contraindicate particular treatments. It is important to differentiate patients with uncontrolled background pain experiencing transient exacerbations of that pain, from patients with controlled background pain experiencing episodes of breakthrough pain. Inadequate reassessment may lead to the continuance of ineffective or inappropriate treatment. A number of different tools have been developed for the assessment of cancer-related pain. Those focusing on breakthrough pain include: the Breakthrough Pain Questionnaire, the Alberta Breakthrough Pain Assessment Tool, and the Breakthrough Pain Assessment Tool.

Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain

2014 ◽  
Vol 19 (7) ◽  
pp. 881-888 ◽  
Author(s):  
R. Sperlinga ◽  
S. Campagna ◽  
A. Berruti ◽  
P. Laciura ◽  
I. Ginosa ◽  
...  
Keyword(s):  
Multicentre Study ◽  
Cancer Patients ◽  
Pain Assessment ◽  
Assessment Tool ◽  
Breakthrough Pain

scholarly journals Validation of the Korean Version of the Breakthrough Pain Assessment Tool in Cancer Patients

2017 ◽  
Vol 54 (3) ◽  
pp. 361-367 ◽  
Author(s):  
Jinyoung Shin ◽  
Sung Jung Cho ◽  
Jungkwon Lee ◽  
Youn Seon Choi
Keyword(s):  
Cancer Patients ◽  
Pain Assessment ◽  
Assessment Tool ◽  
Breakthrough Pain ◽  
Korean Version

scholarly journals Development and Validation of the Breakthrough Pain Assessment Tool (BAT) in Cancer Patients

2014 ◽  
Vol 48 (4) ◽  
pp. 619-631 ◽  
Author(s):  
Katherine Webber ◽  
Andrew N. Davies ◽  
Giovambattista Zeppetella ◽  
Martin R. Cowie
Keyword(s):  
Cancer Patients ◽  
Pain Assessment ◽  
Assessment Tool ◽  
Breakthrough Pain ◽  
Development And Validation

Cultural adaptation and psychometric validation of the Portuguese breakthrough pain assessment tool with cancer patients

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Sónia F. Bernardes ◽  
Marta Matos ◽  
Susana Mourão ◽  
Christin-Melanie Vauclair
Keyword(s):  
Cancer Patients ◽  
Internal Consistency ◽  
Pain Assessment ◽  
Pain Control ◽  
Functional Disability ◽  
Assessment Tool ◽  
Breakthrough Pain ◽  
Pain Severity ◽  
Psychometric Validation ◽  
Effective Management

Abstract Objectives Breakthrough cancer pain (BTcP) is a transient exacerbation of pain that occurs over persistent, stable, and adequately controlled cancer background pain. It is prevalent and bears severe consequences to patients’ quality-of-life. The effective management of BTcP depends on fast and reliable (re)assessment. The Breakthrough pain Assessment Tool (BAT) is one of the most concise and reliable self-report instruments adapted to clinical contexts so far, showing good psychometric qualities in the United Kingdom, the Netherlands, and South Korea. As to promote the effective management of BTcP in Portuguese-speaking communities this study, first aimed to culturally adapt and validate the Portuguese version of the BAT (BAT-Pt). Second, and most importantly, it sought to provide novel evidence on its criterion validity by investigating its association with measures of psychological distress, which has not been yet investigated. Methods The BAT was translated into European Portuguese, using the back-translation method, and culturally adapted. Its psychometric properties (factor structure, internal consistency, construct and criterion validity) were analyzed in a cross-sectional multicenter study, with a sample of 65 cancer patients (49.2% women) recruited from eight hospitals in mainland Portugal (a priori power analysis determined a minimum sample of 50). Health professionals collected patients’ clinical information, assessed their functional disability (ECOG Performance Status) and the adequacy of pain control. In addition to the Portuguese version of the BAT (BAT_Pt), patients completed the Portuguese versions of the Brief Pain Inventory, the Hospital Anxiety and Depression Scale, a Distress Thermometer and answered questions about the adequacy of pain control. Results The BAT-Pt was very well accepted by experts and patients. As hypothesized, a Principal Axis Factor Analysis revealed two underlying factors accounting for 55.2% of the variance: (1) Pain Severity and Impact of BTcP and (2) Duration of BTcP and Medication Inefficacy. Two items (on episode frequency and medication efficacy) were analyzed separately given their lower/cross loadings. The BAT-Pt showed good internal consistency overall (α=0.79) and for each sub-scale, namely, Pain Severity and Impact of BTcP (n=5 items; α=0.86) and Duration of BTcP and Medication Inefficacy (n=2 items; rsb=0.62). The BAT-Pt showed good convergent validity, being moderately to strongly associated with overall pain severity and interference (0.46<r<0.77, p<0.001). It also showed good concurrent validity by being associated not only with physical outcomes – such as functional disability (r=0.40, p<0.001) and patient- and physician-determined adequacy of BTcP control (|0.25<rpb<0.63|, p s <0.05) – but also, with distress (0.33<r<0.46, p s <0.001), anxiety (0.28<r<0.44, p s <0.05) and depression (r=0.47, p<0.001). Conclusions The BAT-Pt is a reliable and valid measure of breakthrough pain in Portuguese cancer patients and it is strongly associated to physical and psychological outcomes. This study confirms and extends the psychometric validation of the BAT to a new cultural context, promoting its diffusion and use by researchers and clinicians in Portuguese-speaking communities. The BAT-Pt may be an invaluable tool for daily clinical practice by tapping multiple aspects of BTcP experiences that are associated to patients’ physical and psychological outcomes.

scholarly journals PO-0900 Translation Comfortneo – A Pain Assessment Tool

2014 ◽  
Vol 99 (Suppl 2) ◽  
pp. A545.2-A545
Author(s):  
R Stenkjaer ◽  
M Andersen ◽  
M Scheutz ◽  
Y Hundrup
Keyword(s):  
Pain Assessment ◽  
Assessment Tool
Sign in / Sign up

Export Citation Format

Share Document